SYKSTRYKER CORP

NYSE stryker.com


$ 349.59 $ 3.64 (1.05 %)    

Thursday, 06-Jun-2024 15:59:49 EDT
QQQ $ 463.32 $ -0.16 (-0.03 %)
DIA $ 389.27 $ 0.80 (0.21 %)
SPY $ 534.63 $ -0.01 (0 %)
TLT $ 93.23 $ -0.14 (-0.15 %)
GLD $ 219.44 $ 1.61 (0.74 %)
$ 349.63
$ 347.13
$ 0.00 x 0
$ 349.77 x 200
$ 344.00 - $ 349.90
$ 248.74 - $ 360.58
1,050,376
na
134.64B
$ 1.19
$ 40.06
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-11-2022 12-31-2021 10-K
11 10-29-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-06-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 07-26-2019 06-30-2019 10-Q
21 04-24-2019 03-31-2019 10-Q
22 02-07-2019 12-31-2018 10-K
23 10-26-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-08-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 02-09-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-22-2016 06-30-2016 10-Q
33 04-22-2016 03-31-2016 10-Q
34 02-11-2016 12-31-2015 10-K
35 10-23-2015 09-30-2015 10-Q
36 07-29-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-12-2015 12-31-2014 10-K
39 10-23-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stryker-to-acquire-privately-held-company-artelon-no-terms-disclosed

Artelon is a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medi...

 goldman-sachs-initiates-coverage-on-stryker-with-neutral-rating-announces-price-target-of-372

Goldman Sachs analyst David Roman initiates coverage on Stryker (NYSE:SYK) with a Neutral rating and announces Price Target ...

 stryker-stock-is-attractive-considering-its-double-digit-organic-revenue-growth---analyst-upgrades-stock

Needham analyst upgrades SYK to Buy, expects new products & M&A to drive upside in revenue & EPS. Strong backlog &a...

 needham-upgrades-stryker-to-buy-announces-392-price-target

Needham analyst Mike Matson upgrades Stryker (NYSE:SYK) from Hold to Buy and announces $392 price target.

 barclays-maintains-overweight-on-stryker-raises-price-target-to-376

Barclays analyst Matt Miksic maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $372 to $376.

 wells-fargo-maintains-overweight-on-stryker-raises-price-target-to-381

Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $364 to ...

 roth-mkm-maintains-buy-on-stryker-raises-price-target-to-405

Roth MKM analyst Jason Wittes maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $348 to $405.

 ubs-maintains-neutral-on-stryker-raises-price-target-to-351

UBS analyst Danielle Antalffy maintains Stryker (NYSE:SYK) with a Neutral and raises the price target from $339 to $351.

 analyst-ratings-for-stryker
Analyst Ratings For Stryker
05/01/2024 14:00:40

 piper-sandler-maintains-overweight-on-stryker-raises-price-target-to-380

Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $375 ...

 stifel-maintains-buy-on-stryker-raises-price-target-to-375

Stifel analyst Rick Wise maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $350 to $375.

 btig-maintains-buy-on-stryker-raises-price-target-to-369

BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $366 to $369.

 baird-maintains-outperform-on-stryker-raises-price-target-to-378

Baird analyst Jeff Johnson maintains Stryker (NYSE:SYK) with a Outperform and raises the price target from $367 to $378.

 needham-reiterates-hold-on-stryker

Needham analyst Mike Matson reiterates Stryker (NYSE:SYK) with a Hold.

 stryker-now-expects-2024-organic-net-sales-growth-of-85-95-prior-75-90-with-pricing-impact-to-be-roughly-flat-raises-adj-eps-outlook-from-1170-1200-to-1185-1205-est-1185

If foreign exchange rates hold near current levels, the company anticipate net sales will be moderately unfavorably impacted fo...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION